INSURE策略治疗新生儿呼吸窘迫综合征的临床研究

黄西林; 陈丹; 李小萍; 李明玉; 沈剑锋; 吴晓松

doi:10.7499/j.issn.1008-8830.2013.01.004

PDF(474 KB)

中国当代儿科杂志 ›› 2013, Vol. 15 ›› Issue (1) : 9-13. DOI: 10.7499/j.issn.1008-8830.2013.01.004

论著·临床研究

INSURE策略治疗新生儿呼吸窘迫综合征的临床研究

黄西林，陈丹，李小萍，李明玉，沈剑锋，吴晓松

作者信息 +

INSURE策略治疗新生儿呼吸窘迫综合征的临床研究

HUANG Xi-Lin, CHEN Dan, LI Xiao-Ping, LI Ming-Yu, SHEN Jian-Feng, WU Xiao-Song

Author information +

文章历史 +

摘要

目的：研究气管插管-肺表面活性物质（PS）-拔管使用鼻塞式气道正压通气（INSURE）策略治疗新生儿呼吸窘迫综合征（NRDS）的有效性和安全性，以及减少肺损伤机制的初步探讨。方法：将2010年3月至2012年3月入院并同意使用PS的NRDS患儿64例随机采用INSURE治疗（观察组）和常频通气（CMV）治疗（对照组），每组各32例。比较两组呼吸功能、上机时间、用氧时间、合并症及转归，测定两组白介素-10（IL-10）、肿瘤坏死因子-α（TNF-α）和血清铁蛋白（SF）的表达差异。结果：治疗后48 h 观察组氧合指数较对照组明显增高，差异有统计学意义（P＜0.05）。观察组呼吸机相关性肺炎（VAP）发生率明显低于对照组（P＜0.05），氧疗时间明显缩短（P＜0.05）。两组上机时间、气胸、颅内出血、坏死性小肠结肠炎、支气管肺发育不良、肺出血的发生率差异无统计学意义（P＞0.05）。观察组TNF-α和SF水平在6 h、24 h、48 h、72 h较对照组明显降低（P＜0.05），IL-10水平较对照组明显增高（P＜0.05）。结论：INSURE策略能更好地改善NRDS患儿氧合功能，减少VAP的发生率，缩短了用氧时间，这可能与其减少TNF-α、SF产生，抑制抗炎因子IL-10减少有关。

Abstract

OBJECTIVE: To evaluate the clinical effectiveness and safety of intubation-surfactant-extubation (INSURE) method in the treatment of neonatal respiratory distress syndrome (NRDS), and to investigate its possible mechanisms. METHODS: Sixty-four premature infants, who were admitted for NRDS and treated with pulmonary surfactant from March 2010 to March 2012, were enrolled in the study. They were randomly divided into INSURE (n=32) and conventional mechanical ventilation (CMV) groups (n=32). The two groups were compared in terms of respiratory function, ventilation time, duration of oxygen therapy, complications, and prognosis, as well as expression of interleukin-10 (IL-10), tumor necrosis factor-α (TNF-α) and serum ferritin (SF). RESULTS: Oxygenation index in the INSURE group was significantly higher than in the CMV group at 48 hours after treatment (P<0.05). Compared with the CMV group, the INSURE group showed significantly lower incidence of ventilator-associated pneumonia (VAP) and significantly shorter duration of oxygen therapy (P<0.05 for all comparisons). There were no significant differences in ventilation time and the incidence of pneumothorax, intracranial hemorrhage, necrotizing enteroolitis, bronchopulmonary dysplasia, and pneumorrhagia between the two groups (P>0.05). The levels of TNF-α and SF were significantly lower in the INSURE group than in the CMV group at 6, 24, 48, and 72 hours after treatment (P<0.05), while the level of IL-10 was significantly higher in the INSURE group than in the CMV group (P<0.05). CONCLUSIONS: INSURE method can improve the oxygenation function of the lung, decrease the incidence of VAP and shorten the duration of oxygen therapy in neonates with NRDS, which is probably due to the fact that this method can reduce the production of TNF-α and SF and inhibit the decrease of IL-10.

导出引用

黄西林，陈丹，李小萍，李明玉，沈剑锋，吴晓松. INSURE策略治疗新生儿呼吸窘迫综合征的临床研究[J]. 中国当代儿科杂志. 2013, 15(1): 9-13 https://doi.org/10.7499/j.issn.1008-8830.2013.01.004

HUANG Xi-Lin, CHEN Dan, LI Xiao-Ping, LI Ming-Yu, SHEN Jian-Feng, WU Xiao-Song. INSURE策略治疗新生儿呼吸窘迫综合征的临床研究[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(1): 9-13 https://doi.org/10.7499/j.issn.1008-8830.2013.01.004

参考文献

［1］Lagercrantz H. Does CPAP work when it really matters?［J］.Acta Paediatr, 2007, 96(4): 481.

［2］Verder H, Bohlin K, Kamper J, Lindwall R, Jonsson B. Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia［J］. Acta Paediatr, 2009, 98(9): 1400-1408.

［3］邵肖梅,叶鸿瑁,丘小汕.实用新生儿学［M］.第4版.北京:人民卫生出版社,2011:395-398.

［4］Sweet D, Bevilacqua G, Carnielli V, Greisen G, Plavka R, Saugstad OD, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome［J］.J Perinat Med, 2007, 35(3): 175-186.

［5］Dani C, Corsini I, Bertini G, Fontanelli G, Pratesi S, Rubaltelli FF. The INSURE method in preterm infants of less than 30 weeks’gestation［J］. J Matern Fetal Neonatal Med, 2010, 23(9): 1024-1029.

［6］高薇薇,谭三智,陈运彬,张永,王越.鼻塞式同步间歇指令通气和持续气道正压通气在早产儿呼吸窘迫综合征中的应用比较［J］.中国当代儿科杂志, 2010, 12(7): 524-526.

［7］Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure［J］. J Perinatol, 2007, 27(7): 422-427.

［8］Dani C, Berti E, Barp J. Risk factors for INSURE failure in preterm infants［J］. Minerva Pediatr, 2010, 62(3 Suppl 1): 19-20.

［9］Bohlin K, Bouhafs RK, Jarstrand C, Curstedt T, Blennow M, Robertson B. Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits［J］. Pediatr Res, 2005, 57(5 Pt 1): 624-630.

［10］刘伟,常立文,李文斌.早产大鼠高氧暴露下肺组织TNF-α、Caspase-3表达时相研究［J］.中国当代儿科杂志,2005,7(5):451-454.

［11］Karemaker R, Kavelaars A, ter Wolbeek M, Tersteeg-Kamperman M, Baerts W, Veen S, et al. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age［J］. Pediatrics, 2008, 121(4): e870-e878.

［12］金敏,张小妮.肺表面活性物质相关蛋白、血清铁蛋白及肿瘤坏死因子α与新生儿呼吸机相关性肺损伤发病的关系［J］.中华围产医学杂志, 2005,8(6):429-431.

［13］Yoon-yub P, Hybertson B, Wright R, Fini M, Elkins N, Repine J. Serum ferritin elevationand acute lung injuy in rats subjected to hemonrage: reduction by mepacrine treatment［J］. Exp Lung Res, 2004, 30(7): 571-584.

［14］Hawkins DL, MacKay RJ, MacKay SL, Moldawer LL.Human interleukin 10 suppresses production of inflammatory mediators by LPS-stimulated equine peritoneal macrophages［J］.Vet Immunol Immuopathol, 1998, 66(1): 1-10.

［15］李红霞,张进川,赵亚力,郝好杰．白细胞介素IL-1O对急性肺损伤炎症／抗炎介质表达的影响［J］.中国危重病急救医学,2005,17(6):338-341.